– Transaction will allow DHT to redeploy capital into new deals generating compounding returns for unitholders –
TORONTO, April 27, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("the Trust") announces that its wholly-owned subsidiary has sold its royalty interest and milestone payment obligations in the worldwide sales of TZIELD™ to a subsidiary of Sanofi S.A. ("Sanofi") for US$210 million.
Read more at newswire.ca